Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03358875 |
|---|---|
| Brief Title: | Comparison of Efficacy and Safety of Anti-PD-1 Antibody BGB-A317 Versus Docetaxel as Treatment in the Second- or Third-line Setting in Participants With NSCLC |
| First Submitted : | November 27, 2017 |
| First Submitted that Met QC Criteria : | November 27, 2017 |
| First Posted : | December 2, 2017 |
| Last Update Submitted that Met QC Criteria : | June 23, 2022 |
| Last Update Posted : | June 27, 2022 |